BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38904726)

  • 1. Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19.
    Nogueira MLC; Lakshmanan R; Rivière G; Mietzsch M; Bennett A; McKenna R; Long JR
    Biomol NMR Assign; 2024 Jun; ():. PubMed ID: 38904726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19.
    Caldas Nogueira ML; Lakshmanan R; Rivière G; Mietzsch M; Bennett A; McKenna R; Long JR
    Res Sq; 2024 Jun; ():. PubMed ID: 38883784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Dynamics and Activity of B19V VP1u during the pHs of Cell Entry and Endosomal Trafficking.
    Lakshmanan RV; Hull JA; Berry L; Burg M; Bothner B; McKenna R; Agbandje-McKenna M
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Domain Segmentation of B19V VP1u Using Intein Technology for Structural Studies.
    Lakshmanan RV; Agbandje-McKenna M; McKenna R
    Protein Pept Lett; 2024; 31(2):161-167. PubMed ID: 38243925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VP1u of Human Parvovirus B19: A Multifunctional Capsid Protein with Biotechnological Applications.
    Ros C; Bieri J; Leisi R
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33352888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal 5-68 amino acids domain of the minor capsid protein VP1 of human parvovirus B19 enters human erythroid progenitors and inhibits B19 infection.
    Zou W; Ning K; Xu P; Deng X; Cheng F; Kleiboeker S; Qiu J
    J Virol; 2021 Jun; 95(14):. PubMed ID: 33952637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.
    Leisi R; Di Tommaso C; Kempf C; Ros C
    Viruses; 2016 Feb; 8(3):61. PubMed ID: 26927158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.
    Leisi R; Von Nordheim M; Ros C; Kempf C
    Viruses; 2016 Sep; 8(10):. PubMed ID: 27690083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Conserved Receptor-Binding Domain in the VP1u of Primate Erythroparvoviruses Determines the Marked Tropism for Erythroid Cells.
    Bircher C; Bieri J; Assaraf R; Leisi R; Ros C
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.
    Deng X; Dong Y; Yi Q; Huang Y; Zhao D; Yang Y; Tijssen P; Qiu J; Liu K; Li Y
    PLoS One; 2013; 8(4):e61440. PubMed ID: 23596524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.
    Bieri J; Ros C
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.
    Leisi R; Ruprecht N; Kempf C; Ros C
    J Virol; 2013 Dec; 87(24):13161-7. PubMed ID: 24067971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice.
    Hsu TC; Chiu CC; Chang SC; Chan HC; Shi YF; Chen TY; Tzang BS
    Virulence; 2016; 7(2):110-8. PubMed ID: 26632342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the Functional VP1 Unique Region of Human Parvovirus B19 in Causing Skin Fibrosis of Systemic Sclerosis.
    Chen DY; Tzang CC; Liu CM; Chiu TM; Lin JW; Chuang PH; Kuo CW; Tzang BS; Hsu TC
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The VP1 unique region of human parvovirus B19 and human bocavirus induce lung injury in naïve Balb/c mice.
    Lin CY; Chung YH; Shi YF; Tzang BS; Hsu TC
    PLoS One; 2018; 13(8):e0202667. PubMed ID: 30114253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.
    Bönsch C; Kempf C; Ros C
    J Virol; 2008 Dec; 82(23):11784-91. PubMed ID: 18815302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of human Parvovirus B19 and Bocavirus VP1 unique region on tight junction of human airway epithelial A549 cells.
    Chiu CC; Shi YF; Yang JJ; Hsiao YC; Tzang BS; Hsu TC
    PLoS One; 2014; 9(9):e107970. PubMed ID: 25268969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro refolding of the structural protein VP1 of parvovirus B19 produces virus-like particles with functional VP1 unique region.
    Soto-Valerio IA; Cayetano-Cruz M; Valadez-García J; Guadarrama P; Méndez C; Bustos-Jaimes I
    Virology; 2022 May; 570():57-66. PubMed ID: 35367742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.
    Ros C; Gerber M; Kempf C
    J Virol; 2006 Dec; 80(24):12017-24. PubMed ID: 17020940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
    Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
    Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.